Related Experiment Video
Updated: Aug 15, 2025

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma
Shengjian Jin1, Yasusei Kudo1, Taigo Horiguchi1
1Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8504, Japan.
Abstract:
Ubiquitination and deubiquitination are two popular ways for the post-translational modification of proteins. These two modifications affect intracellular localization, stability, and function of target proteins. The process of deubiquitination is involved in histone modification, cell cycle regulation, cell differentiation, apoptosis, endocytosis, autophagy, and DNA repair after damage. Moreover, it is involved in the processes of carcinogenesis and cancer development. In this review, we discuss these issues in understanding deubiquitinating enzyme (DUB) function in head and neck squamous cell carcinoma (HNSCC), and their potential therapeutic strategies for HNSCC patients are also discussed.
Insights
Deubiquitination, a protein modification process, plays a key role in cancer development. This review explores deubiquitinating enzyme (DUB) functions and therapeutic strategies for head and neck squamous cell carcinoma (HNSCC).
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ubiquitination and deubiquitination are crucial post-translational modifications regulating protein localization, stability, and function.
- Deubiquitination is implicated in diverse cellular processes including DNA repair, cell cycle regulation, and apoptosis.
- Dysregulation of deubiquitination is linked to carcinogenesis and cancer progression.
Purpose of the Study:
- To review the role of deubiquitinating enzymes (DUBs) in head and neck squamous cell carcinoma (HNSCC).
- To discuss the functional significance of DUBs in HNSCC pathogenesis.
- To explore potential therapeutic strategies targeting DUBs for HNSCC treatment.
Main Methods:
- Literature review of studies on deubiquitination and HNSCC.
- Analysis of the involvement of DUBs in cellular pathways relevant to HNSCC.
- Synthesis of current knowledge on DUB inhibitors and their therapeutic potential.
Main Results:
- Deubiquitinating enzymes significantly influence HNSCC development and progression.
- Specific DUBs are identified as potential biomarkers and therapeutic targets in HNSCC.
- Targeting DUBs offers promising avenues for novel HNSCC therapies.
Conclusions:
- Deubiquitinating enzymes are critical regulators in head and neck squamous cell carcinoma.
- Understanding DUB function is essential for developing effective HNSCC treatments.
- Targeting DUBs represents a promising therapeutic strategy for HNSCC patients.
More Related Videos
11:36In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex